B the Inspiration!
I’m a believer in the power of stories. By sharing our personal stories, we can connect, inspire and support each other. This week I’d like to share an exciting new opportunity for the hemophilia B community.
What’s your story? A new RIXUBIS [Coagulation Factor IX (Recombinant)] program gives you the chance to share it.
Whether you’re a patient or caregiver, you’ve got stories about life with hemophilia B: stories of resilience, triumphs, and what keeps you going each day.
RIXUBIS has launched a vibrant new program called B the Inspiration, created just for the hemophilia B community. See real people’s stories. Show your support and share your story, too.
For now, check out the RIXUBIS Facebook page. And be sure to check soon for a special new section of the RIXUBIS website, www.rixubis.com, where these stories truly come to life. Get inspired—and be inspiring to others.
And here’s the technica/medical info I need to include in this blog…
Indications and Important Risk Information for RIXUBIS [Coagulation Factor IX (Recombinant)]
RIXUBIS is an injectable medicine used to replace clotting factor IX that is missing in adults and children with hemophilia B (also called congenital factor IX deficiency or Christmas disease).
RIXUBIS is used to control and prevent bleeding in people with hemophilia B. Your healthcare provider may give you RIXUBIS when you have surgery. RIXUBIS can reduce the number of bleeding episodes when used regularly (prophylaxis).
Detailed Important Risk Information
You should not use RIXUBIS if you are allergic to hamsters or any ingredients in RIXUBIS.
You should tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, such as over-the-counter medicines, supplements or herbal remedies, have any allergies, including allergies to hamsters, are nursing, are pregnant or planning to become pregnant, or have been told that you have inhibitors to factor IX.
Allergic reactions have been reported with RIXUBIS. Call your healthcare provider or get emergency treatment right away if you get a rash or hives, itching, tightness of the throat, chest pain or tightness, difficulty breathing, lightheadedness, dizziness, nausea, or fainting.
Your body may form inhibitors to factor IX. An inhibitor is part of the body’s defense system. If you form inhibitors, it may stop RIXUBIS from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for development of inhibitors to factor IX.
If you have risk factors for developing blood clots, the use of factor IX products may increase the risk of abnormal blood clots.
Common side effects that have been reported with RIXUBIS include: unusual taste in the mouth, limb pain, and atypical blood test results.
Call your healthcare provider right away about any side effects that bother you or if your bleeding does not stop after taking RIXUBIS.
Please see RIXUBIS full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Baxalta and Rixubis are trademarks of Baxalta Incorporated. This is a paid annoucement by Baxalta.